D-threo-PDMP
D-threo-PDMP is a potent glucoceramide synthase (GCS) inhibitor, which reduces the glycosphingolipids (such as GM3 and GD3) on the cell surface by inhibiting glycosylation, reduces the total length of the axon plexus and the number of axon branch points, and inhibits neurite growth. D-threo-PDMP inhibits the synthesis of GM3, thereby reducing the adhesion ability of B16 melanoma cells and mimicking the pathological effects of hyperglycemia/TGF-β1. D-threo-PDMP inhibits the synthesis of GD3, thereby protecting liver cells from apoptosis induced by TNF-α. D-threo-PDMP can be used to study diseases related to targeted glycosphingolipid metabolism[1][2][3][4].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Glucosylceramide Synthase (GCS)
Type
Reference compound
Related Pathways
Apoptosis; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/d-threo-pdmp.html
Purity
99.50
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
CCCCCCCCCC(N[C@H](CN1CCOCC1)[C@H](O)C2=CC=CC=C2)=O
Molecular Formula
C23H38N2O3
Molecular Weight
390.56
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-116392E/D-threo-PDMP-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-116392E/D-threo-PDMP-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[109836-82-0]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Natriuretic Peptide Receptor B (NPR2) (NM_003995) Human Tagged ORF Clone Lentiviral Particle
